Clinical Trial Update: Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dexmedetomidine in acute stroke interventions and cerebral vasospasm; the study was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Ischemia
• Stroke

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Stroke, Brain Ischemia | Phase 2 | Status: TERMINATED | Results posted: 2022-12-28